We only have this paper's title and publication details.
Read it at the sourceInhibition of fibulin-3 increases macrophage activation and reduces immunosuppressive signaling in glioblastoma.
Figure S6. Fibulin-3 induces p65/RelA binding to the CSF1 promoter.
No takes yet. Share an insight, caveat, or question.
Kundu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: